Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 19 Apr 2006, 14:38 Medi-Clinic - Trading Statement
MDC
 MDC                                                                             
Medi-Clinic - Trading Statement                                                 
Medi-Clinic Corporation Limited                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number 1983/010725/06)                                            
JSE share code: MDC                                                             
ISIN: ZAE000074142                                                              
("Medi-Clinic" or "the Company")                                                
TRADING STATEMENT                                                               
The operational performance of Medi-Clinic for the year ended 31 March 2006 is  
consistent with historical performance and is not the subject of this trading   
statement.                                                                      
Shareholders are referred to the circular to shareholders dated 1 November 2005 
("the circular") presenting details of the black ownership initiative and the   
capital restructuring ("the transactions") announced on 4 October 2005 ("the    
announcement").  The effect of the transactions on the earnings per share       
("EPS") and headline earnings per share ("HEPS") of the Company was fully       
disclosed in the circular.                                                      
The South African Institute of Chartered Accountants ("SAICA") has finalised    
both the exposure drafts mentioned in the announcement and the circular, which  
deals with the accounting for Black Economic Empowerment transactions under     
International Financial Reporting Standard 2 - Share Based Payments ("IFRS 2"). 
SAICA issued IFRIC 8(AC 441)- Scope of IFRS 2 and AC 503 - Accounting for Black 
Economic Empowerment (BEE) Transactions. Based on this, IFRS 2 has become       
applicable to the entire black ownership initiative. The application of IFRIC 8 
(AC 441) and AC 503 has an effect on the earnings for the year ended 31 March   
2006 of a once-off charge to the income statement of Medi-Clinic in the amount  
of R85 million, with a corresponding increase in equity (a separate reserve).   
Shareholders are, accordingly, advised that the EPS and HEPS will be between 40%
and 50% lower than the corresponding reporting period of the previous year,     
respectively, mainly as a result of the financial and accounting effect of the  
transactions and the BEE charge referred to above.                              
Core EPS will exclude the once off effect of the STC payable on the special     
dividend, which formed part of the capital restructuring, as well as the BEE    
charge referred to above.  Core EPS will be between 0% and 10% higher than the  
corresponding reporting period of the previous year. This figure will include   
the higher interest charges as a result of the capital restructuring.           
The financial information on which this trading statement is based has not been 
reviewed nor reported on by the Company"s external auditors.                    
Stellenbosch                                                                    
19 April 2006                                                                   
Sponsor                                                                         
RAND MERCHANT BANK (A division of FirstRand Bank Limited)                       
Date: 19/04/2006 02:38:03 PM Produced by the JSE SENS Department                
                                                                                
                                                                                
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: